The most expensive stock in a week in the Chinese stock market was BYD, the “favorite company for Ch..

The most expensive stock in a week in the Chinese stock market was BYD, the “favorite company for Chinese ants.” Guizuma Otay, Hangseo Pharmaceutical, and “Chinese version of Nvidia” Cambricon were also counted as the “top 10” companies in transaction.

According to the financial investment industry on the 31st, the top stocks in mainland China’s stock market from the 24th to the 28th are BYD, CATL, money mining, Sangyo Bank, Guizuma Otai, and Cambricon.

Electric vehicle maker BYD and battery maker CATL ranked first and second respectively, trading 9.6 billion yuan (about 1.9 trillion won) and 6.4 billion yuan (about 1.3 trillion won), respectively. As of 4 p.m., BYD was trading at 374.85 yuan, down 0.14% from its closing price a week ago, while CATL was trading at 252.58 yuan, down 2.18%.

Financing Mining (5.7 billion yuan), which ranked third, is a state-owned mineral developer in China and has benefited from the recent rise in gold and copper prices.

Morgan Stanley recommended increasing the weight, saying, “Copper prices have surpassed the highest price in history, but the valuation of the money mining industry remains attractive.” The money mining industry has seen its stock price rise 19% this year.

As the Chinese government eased lending regulations and came up with measures to boost consumption to boost the domestic economy, transactions between financial and consumer stocks also rose to the top. The fourth-ranked Sangyo Bank traded 5.4 billion yuan (about 1.1 trillion won), while the fifth-ranked Guizuma Otai traded 5.1 billion yuan (about 1 trillion won). The stock prices of the two companies rose 12.4% and 4.9%, respectively, from the beginning of the year.

Cambricon, a high-performance artificial intelligence (AI) chip designer, ranked sixth, trading 4.6 billion yuan (about 930 billion won) during the period.

Cambricon, whose stock price soared 383% last year due to the “AI semiconductor boom,” benefited from U.S. AI chip designer Nvidia’s export regulations to China.

Hangseo Pharmaceutical, an anticancer drug developer, ranked 10th with 3 billion yuan (about 600 billion won). The company, which invests 1 trillion won in R&D every year, has seen its stock price rise 9.5 percent this year.

The tally did not include unlisted companies on the mainland stock market, such as Baidu, Alibaba, Tencent, and Xiaomi.

Domestic middle school ants are also buying a large number of the top stocks on the mainland Chinese stock market. According to the Korea Securities Depository, as of the 28th, middle school ants had the largest number of BYD ($157 million), Hangseo Pharmaceutical ($133 million), and Guizuma Otai ($63 million), excluding the Hong Kong stock market.